BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 19051424)

  • 61. A sacrifice for others? Ethical dilemmas surrounding the UK randomised trial for the management of screen-detected ductal carcinoma in situ of the breast.
    Thornton H
    Prof Nurse; 1993 Mar; 8(6):402-4. PubMed ID: 8383335
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Primary breast lymphoma: case reports and review of the literature.
    Sanguinetti A; Ragusa M; Lucchini R; Monacelli M; Calzolari F; Misso C; Avenia N
    G Chir; 2008 May; 29(5):230-2. PubMed ID: 18507958
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Survival with metastatic breast cancer for 24 years.
    Ana JN; Thompson SG; Williams MV; Eakins D
    Eur J Surg; 1993 Apr; 159(4):239-40. PubMed ID: 8102546
    [No Abstract]   [Full Text] [Related]  

  • 64. The diagnosis and management of pre-invasive breast disease: another point of view.
    Badve S
    Breast Cancer Res; 2004; 6(1):E3; discussion E4. PubMed ID: 14680489
    [No Abstract]   [Full Text] [Related]  

  • 65. Breast cancer: non-metastatic.
    Dixon JM; Gregory K; Johnston S; Rodger A
    Clin Evid; 2002 Dec; (8):1811-39. PubMed ID: 12603971
    [No Abstract]   [Full Text] [Related]  

  • 66. Ductal carcinoma in situ of the breast.
    Kettritz U
    N Engl J Med; 2004 Jul; 351(4):399-402; author reply 399-402. PubMed ID: 15278957
    [No Abstract]   [Full Text] [Related]  

  • 67. Treatment of early-stage breast cancer.
    Curr Probl Cancer; 1999; 23(4):149-228. PubMed ID: 10485445
    [No Abstract]   [Full Text] [Related]  

  • 68. DCIS of the breast: Are we over-diagnosing it? Are we over-treating it?
    Leeper AD; Dixon JM
    Maturitas; 2011 Apr; 68(4):295-6. PubMed ID: 21273014
    [No Abstract]   [Full Text] [Related]  

  • 69. Current management of DCIS: a review.
    Patani N; Cutuli B; Mokbel K
    Breast Cancer Res Treat; 2008 Sep; 111(1):1-10. PubMed ID: 17902049
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [The treatment of ductal carcinoma in situ (DCIS) of the breast].
    Brandts F
    Ned Tijdschr Geneeskd; 2004 Mar; 148(10):505; author reply 505. PubMed ID: 15042902
    [No Abstract]   [Full Text] [Related]  

  • 71. A Call for Change in the Diagnosis and Treatment of Patients with Ductal Carcinoma In Situ: An Opportunity to Minimize Overdiagnosis and Overtreatment.
    Masood S
    Breast J; 2015; 21(6):575-8. PubMed ID: 26547899
    [No Abstract]   [Full Text] [Related]  

  • 72. Development of vaccines for high-risk ductal carcinoma in situ of the breast.
    Czerniecki BJ; Roses RE; Koski GK
    Cancer Res; 2007 Jul; 67(14):6531-4. PubMed ID: 17638860
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Re-excision for ductal carcinoma in situ: the surgeon's least favorite operation.
    Ward BA; Latrenta L
    Cancer J; 2006; 12(1):14-6. PubMed ID: 16613655
    [No Abstract]   [Full Text] [Related]  

  • 74. Management of breast cancer in elderly patients.
    Reginelli A; Calvanese M; Ravo V; Di Franco R; Silvestro G; Gatta G; Squillaci E; Grassi R; Cappabianca S
    Int J Surg; 2014; 12 Suppl 2():S187-S192. PubMed ID: 25157989
    [TBL] [Abstract][Full Text] [Related]  

  • 75. 1991 RSNA special focus session: current controversies in the management of ductal carcinoma in situ of the breast.
    Wilson JF; Destouet JM; Winchester DP; Kuske RR; Vogel VG
    Radiology; 1992 Oct; 185(1):77-81. PubMed ID: 1326120
    [No Abstract]   [Full Text] [Related]  

  • 76. Treatment selection in ductal carcinoma in situ.
    Morrow M; Schnitt SJ
    JAMA; 2000 Jan; 283(4):453-5. PubMed ID: 10659859
    [No Abstract]   [Full Text] [Related]  

  • 77. Controversies over the role of radiation therapy for ductal carcinoma in situ.
    Smith BD; Smith GL; Buchholz TA
    Expert Rev Anticancer Ther; 2008 Mar; 8(3):433-41. PubMed ID: 18366290
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Partial breast brachytherapy as the primary treatment for breast cancer diagnosed after mantle radiation therapy for Hodgkin's disease.
    Chadha M; Yoon H; Feldman S; Shah N; Moore E; Harrison LB
    Am J Clin Oncol; 2009 Apr; 32(2):132-6. PubMed ID: 19307955
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Successful pregnancy outcome with 5-flurouracil, epirubicin, cyclophosphamide chemotherapy, and hemostatic radiotherapy with abdominal shielding for metastatic invasive intraductal breast carcinoma.
    Sharma JB; Pushparaj M; Kumar S; Roy KK; Raina V; Malhotra N
    Arch Gynecol Obstet; 2009 Mar; 279(3):415-7. PubMed ID: 18642013
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Molecular advances in early breast cancer. Breast cancers are as diverse as the women who have them. Now experts are using gene-based information to tailor treatment.
    Harv Womens Health Watch; 2009 Oct; 17(2):1-3. PubMed ID: 19998551
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.